Therefore, we analyzed the gliomas’ immune checkpoint, and multiple abnormal immune checkpoints were found in the high RS group, and many of them have been reported to participate in the regulation of the growth of gliomas, such as CD44, CD86, and HAVCR2 (44–46). Here, CD44 is linked to central nervous system cancer.